Phenytoin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Phenytoin and local guidelines before prescribing.
Mechanism
Blocks voltage-gated sodium channels.
Uses
Focal and generalised tonic-clonic seizures, status epilepticus (second line).
Dosing
Quick reference (Makindo topics site)
| Main use | Adult dose | Key pearl / caution |
|---|---|---|
| Second-line status epilepticus | 15–20 mg/kg IV at ≤50 mg/min | ECG and BP monitoring needed. |
Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.
- Increased dose needs - pregnancy (increase as soon as pregnancy is confirmed - often by 25–50 micrograms - and check TFTs each trimester), oral oestrogen, enzyme inducers (rifampicin, carbamazepine, phenytoin), weight gain.
Endocrine: Anatomy Physiology and Pharmacology - Phenytoin level | About 10–20 mg/L (correct for low albumin)
Neurology: Anatomy, Physiology and Pharmacology - IV phenytoin - hypotension , arrhythmias and heart block (give no faster than 50 mg/min with ECG and blood pressure monitoring ), "purple glove" tissue damage.
Neurology: Anatomy, Physiology and Pharmacology - Status epilepticus | Benzodiazepine (IV lorazepam 4 mg or buccal midazolam 10 mg), repeat at 5–10 minutes; then levetiracetam, phenytoin or valproate; ICU
Neurology: Emergencies
4 more dose entries from the chapters
- Phenytoin IV (20 mg/kg, no faster than 50 mg/minute, with ECG and BP monitoring).
Neurology: Emergencies - Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
Obstetrics - Second line — levetiracetam (40–60 mg/kg), phenytoin (20 mg/kg) or sodium valproate (40 mg/kg) over 5–20 minutes.
Emergency Medicine: Paediatric emergency medicine - Loading dose - a larger first dose to reach the target level quickly, when waiting 4–5 half-lives would be too slow: digoxin , amiodarone , phenytoin (and levetiracetam in status), vancomycin , teicoplanin, aminophylline , warfarin (in some regimens), clopidogrel (300–600 mg in ACS), ticagrelor.
Clinical pharmacology and prescribing: Principles of clinical pharmacology
Side effects
Nystagmus, ataxia, gingival hyperplasia, hirsutism, rash, osteomalacia; IV causes hypotension and arrhythmia.
Interactions
Strong enzyme inducer; many interactions including warfarin and contraceptives; amiodarone and fluconazole raise levels.
Contraindications and cautions
AV block, sinus bradycardia
Monitoring
Level, ECG and BP during IV
Pregnancy and breastfeeding
Teratogenic; specialist advice
Renal and hepatic impairment
Adjust by level; reduce in liver impairment
Overdose and reversal
Supportive
Special advice
Non-linear kinetics; monitor levels; IV must be slow with ECG and BP monitoring; avoid extravasation.
More from the textbook: uses, cautions and other points
- Many interactions - enzyme inhibitors raise INR (amiodarone, clarithromycin, erythromycin, fluconazole, metronidazole, ciprofloxacin, alcohol binges); inducers lower it (rifampicin, carbamazepine, phenytoin, St John's wort); diet (vitamin K-rich foods).
Cardiology: Anatomy Physiology and Pharmacology - Metabolised by CYP1A2 - levels raised by ciprofloxacin , clarithromycin , erythromycin, fluvoxamine, cimetidine, heart failure, liver disease, viral infection, stopping smoking; lowered by smoking , rifampicin, carbamazepine, phenytoin, alcohol.
Respiratory: Anatomy, Physiology and Pharmacology - Interactions - CYP3A4 inhibitors (ritonavir and cobicistat, itraconazole, clarithromycin) block breakdown of inhaled or nasal fluticasone and budesonide → Cushing's syndrome and adrenal suppression; enzyme inducers (rifampicin, carbamazepine, phenytoin) reduce steroid effect - double replacement doses may be needed.
Endocrine: Anatomy Physiology and Pharmacology - Enzyme inducers (rifampicin, carbamazepine, phenytoin) increase steroid requirements.
Endocrinology: Adrenal Disease - Enzyme inducers (rifampicin, phenytoin, carbamazepine): Speed up steroid breakdown, which can precipitate crisis in treated patients. They may need higher doses.
Endocrinology: Adrenal Disease - Enzyme inducers (carbamazepine, phenytoin, rifampicin) speed up breakdown.
Endocrinology: Thyroid disease
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Respiratory: Anatomy, Physiology and Pharmacology (1 mention)
- Endocrine: Anatomy Physiology and Pharmacology (2 mentions)
- Endocrinology: Adrenal Disease (2 mentions)
- Endocrinology: Thyroid disease (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (3 mentions)
- Gastroenterology: Investigations (2 mentions)
- Gastroenterology: Liver disease (2 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (18 mentions)
- Neurology: Emergencies (5 mentions)
- Neurology: Localisation and Investigation (1 mention)
- Neurology: Epilepsy (6 mentions)
- Neurology: Movement Disorders (2 mentions)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (1 mention)
- Renal: Dialysis and Transplant (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (6 mentions)
- Haematology: History and Examination (3 mentions)
- Haematology: Anaemia (1 mention)
- Haematology: Haemostasis and Thrombosis (1 mention)
- Paediatrics: Neonatology (1 mention)
- Paediatrics: Neurology, bones and joints in children (4 mentions)
- Obstetrics (2 mentions)
- Obstetrics: Medical Problems (1 mention)
- Gynaecology: Fertility Contraception Menopause (1 mention)